Net Cash Provided by (Used in) Operating Activities of BIOADAPTIVES, INC. from 30 Sep 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
BIOADAPTIVES, INC. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Sep 2013 to 31 Mar 2025.
  • BIOADAPTIVES, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $97,906, a 138% decline year-over-year.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $249,517, a 12% decline from 2023.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $223,773, a 1.5% increase from 2022.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $227,259, a 43% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

BIOADAPTIVES, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $97,906 -$56,725 -138% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $41,181 -$21,720 -112% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $19,461 +$41,696 +68% 01 Jan 2023 31 Mar 2023 10-Q 17 May 2024 2024 Q1
Q1 2022 $61,157 -$796 -1.3% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $60,361 -$18,047 -43% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $42,314 +$4,582 +9.8% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $46,896 01 Jan 2019 31 Mar 2019 10-Q/A 11 Jun 2020 2020 Q1
Q1 2016 $1,713 -$1,350 -372% 01 Jan 2016 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q1 2015 $363 +$6,705 +95% 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q1 2014 $7,068 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015 2015 Q1
Q3 2013 $749 01 Jul 2013 30 Sep 2013 10-Q 21 Oct 2013 2013 Q3

BIOADAPTIVES, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $249,517 -$25,744 -12% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $223,773 +$3,486 +1.5% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $227,259 -$68,608 -43% 01 Jan 2022 31 Dec 2022 10-K 10 Apr 2024 2023 FY
2021 $158,651 -$51,762 -48% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $106,889 +$61,231 +36% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $168,120 +$252,025 +60% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $420,145 01 Jan 2018 31 Dec 2018 10-K/A 12 May 2020 2019 FY
2015 $72* +$58,556 01 Jan 2015 31 Dec 2015 10-K 14 Apr 2016 2015 FY
2014 $58,628 -$32,581 -125% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
2013 $26,047 19 Apr 2013 31 Mar 2014 10-Q 20 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.